Travoprost Ophthalmic Solution
Product Images NDC 42571-130

6 FDA label images from Micro Labs Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic (NDC 42571-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Travoprost-str.jpg (Travoprost Str)

Travoprost-str.jpg (Travoprost Str)
Chemical structure of Travoprost, the active ingredient in Travoprost Ophthalmic Solution 0.04 mg/mL by Micro Labs Limited. The structure features multiple rings, hydroxyl groups, and fluorinated benzene.*
FDA Label Image

Travoprost-figa.jpg (Travoprost Figa)

Travoprost-figa.jpg (Travoprost Figa)
An instructional illustration diagram of an ophthalmic solution bottle showing its parts. The diagram labels the cap, the bottle, and the tear off tamper evident ring around the neck of the bottle, identified as Fig. A.*
FDA Label Image

Travoprost-figb.jpg (Travoprost Figb)

Travoprost-figb.jpg (Travoprost Figb)
An instructional diagram showing a hand holding a small bottle, likely an ophthalmic solution bottle, with the other hand removing or adjusting the protective seal around the cap. The figure is labeled 'Fig. B.'*
FDA Label Image

Travoprost-figc.jpg (Travoprost Figc)

Travoprost-figc.jpg (Travoprost Figc)
An instructional illustration showing hands holding an ophthalmic solution bottle and twisting the cap to open or close it, likely part of usage or administration instructions for Travoprost Ophthalmic Solution.*
FDA Label Image

Travoprost-labl.jpg (Travoprost Labl)

Travoprost-labl.jpg (Travoprost Labl)
Label for Travoprost Ophthalmic Solution USP 0.004% (0.04 mg/mL) ophthalmic solution in a 2.5 mL bottle. The label indicates it is an ionic buffered solution for use in the eyes only. Manufactured by Micro Labs Limited, India, for Micro Labs USA, Inc. Storage instructions and dosage note are included along with NDC 42571-130-27.*
FDA Label Image

Travoprost-crtn.jpg (Travoprost Crtn)

Travoprost-crtn.jpg (Travoprost Crtn)
Packaging label for Travoprost Ophthalmic Solution USP 0.004% (Ionic Buffered Solution) by Micro Labs Limited. The ophthalmic solution is supplied in a 2.5 mL bottle, labeled for prescription use only. The label includes active and inactive ingredient information, storage instructions, and manufacturer details for Micro Labs USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.